Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...

Exeter Chiefs made 12 changes to their side for the trip to Ulster in the Champions Cup Exeter Chiefs boss Rob Baxter said he feels fielding a much-changed side in their final European Champions ...

(Bloomberg) -- Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp., according to people familiar with the matter. The partnership at ...

In a report released yesterday, J. Bruce Chan from Stifel Nicolaus maintained a Buy rating on ArcBest (ARCB – Research Report), with a price target of $109.00. The company’s shares closed ...

On Monday, Stifel analysts maintained a Buy rating on ServiceTitan stock (NASDAQ:TTAN) with a steady price target of $120.00. The company, currently trading at $92.56 with a market capitalization ...

Gifting allows recipients to access the article for free. On the heels of a major companywide restructuring, Baxter International told investors at the JP Morgan Healthcare Conference today that ...

Exeter have never been on as difficult a run as they are now since Rob Baxter became boss in 2009 Exeter director of rugby Rob Baxter says it is up to him and his coaches to get the side out of ...

Exeter director of rugby Rob Baxter says it is up to him and his coaches to get the side out of its current poor run of form. The Chiefs were thrashed 69-17 by French Top 14 leaders Bordeaux in ...